Back to Browse Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 2 » Issue 1

Influenza infection and COPD

Authors Patrick Mallia, Sebastian L Johnston

Published 15 April 2007 Volume 2007:2(1) Pages 55—64

Patrick Mallia, Sebastian L Johnston

Department of Respiratory Medicine, National Heart and Lung Institute and Wright Fleming Institute of Infection & Immunity, Imperial College London, UK

Abstract: Influenza is a disease with global impact that causes enormous morbidity and mortality on an annual basis. It primarily infects the respiratory tract and causes a broad range of illness ranging from symptomless infection to fulminant primary viral and secondary bacterial pneumonia. The severity of infection depends on both the virus strain and a number of host factors, primarily age and the presence of comorbid conditions such as cardiopulmonary disease. The mortality and utilization of healthcare resources associated with influenza is concentrated in the elderly and those with coexisting disease such as chronic obstructive pulmonary disease (COPD). Increasing use of vaccination and the development of new antiviral drugs hold out hope that the burden of disease associated with influenza can be reduced. However the constant emergence of new influenza strains and the current risk of avian influenza pandemic serve as warnings that influenza will remain a serious pathogen for the foreseeable future.

Keywords: COPD, influenza, exacerbations.

Download Article [PDF] 

Readers of this article also read:

Continuing to Confront COPD International Patient Survey: methods, COPD prevalence, and disease burden in 2012–2013

Landis SH, Muellerova H, Mannino DM, Menezes AM, Han MK, van der Molen T, Ichinose M, Aisanov Z, Oh YM, Davis KJ

International Journal of Chronic Obstructive Pulmonary Disease 2014, 9:597-611

Published Date: 6 June 2014

Anacetrapib: potential for the prevention and treatment of coronary heart disease

Steen DL, Khera AV, Cannon CP

Research Reports in Clinical Cardiology 2013, 4:39-53

Published Date: 4 April 2013

Controlled-release approaches towards the chemotherapy of tuberculosis

Saifullah B, Hussein MZ, Hussein Al Ali SH

International Journal of Nanomedicine 2012, 7:5451-5463

Published Date: 12 October 2012

Nucleocytoplasmic transport blockage by SV40 peptide-modified gold nanoparticles induces cellular autophagy

Tsai TL, Hou CC, Wang HC, Yang ZS, Yeh CS, Shieh DB, Su WC

International Journal of Nanomedicine 2012, 7:5215-5234

Published Date: 8 October 2012

Epigenomics in cancer management

Fabricio F Costa

Cancer Management and Research 2010, 2:255-265

Published Date: 27 October 2010

Exacerbation rate, health status and mortality in COPD – a review of potential interventions

Terence AR Seemungal, John R Hurst, Jadwiga A Wedzicha

International Journal of Chronic Obstructive Pulmonary Disease 2009, 4:203-223

Published Date: 29 May 2009

Effects of active tobacco smoking on the prevalence of asthma-like symptoms in adolescents

Javier Mallol, José A Castro-Rodriguez, Eliana Cortez

International Journal of Chronic Obstructive Pulmonary Disease 2007, 2:65-69

Published Date: 15 April 2007

Variability of exhaled breath condensate leukotriene B4 and 8-isoprostane in COPD patients

Zoë L Borrill, R Cerys Starkey, S Dave Singh

International Journal of Chronic Obstructive Pulmonary Disease 2007, 2:71-76

Published Date: 15 April 2007